Survivin Promotes Piperlongumine Resistance in Ovarian Cancer
Xing-Wei Nan(Wenzhou Medical University), Xiaojian Yan(Women's Hospital, School of Medicine, Zhejiang University)
Cited by 16
Related Papers
Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer
|Frontiers in Oncology|2019|133
Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells
|Oxidative Medicine and Cellular Longevity|2014|88